AUS
NZ
UK
CA
USA
IND
Castle Minerals Limited (ASX:CDT) has announced that a total of 5,429,504 unquoted options expired unexercised on 20 July 2026, resulting in their automatic cessation. This expiry involved two distinct option series, both with an exercise price of $0.225 and identical maturity dates. The event impacts the company’s issued capital structure as these securities naturally reached their contractual termination.
Key Points
- Castle Minerals Limited (CDT) is an Australian mineral exploration firm listed on the ASX, focusing on advancing exploration assets and managing its capital structure.
- On 20 July 2026, 5,429,504 unquoted options expired across two security codes: 1,948,033 options under CDTAO and 3,481,471 options under CDTAD, both with a $0.225 exercise price.
- Neither option series was exercised or converted into ordinary shares, resulting in complete cessation of these securities.
- Post-expiry, Castle Minerals’ issued capital includes 177,145,535 fully paid ordinary shares quoted on the ASX and approximately 133.8 million remaining unquoted options and performance rights.
- The company continues to hold unquoted options under CDTAE, CDTAF, CDTAN, and CDTAG codes, with expiry dates spanning from December 2026 through May 2028.
Details on Castle Minerals’ Unquoted Option Expiry
Castle Minerals Limited confirmed that two unquoted option series, CDTAO and CDTAD, expired on 20 July 2026 without any holder exercising their rights. The CDTAO series consisted of 1,948,033 non-transferable options, while the CDTAD series included 3,481,471 options. Both sets carried the same exercise price of $0.225 per share and reached maturity without conversion into ordinary equity. The company did not incur any consideration related to these expiries, consistent with the automatic termination of options upon expiry without exercise.
This outcome aligns with typical options market practices, where holders must actively exercise options before expiry or forfeit them. The simultaneous expiry of these two series, despite differing security codes, suggests they may have originated from separate issuance events or employee incentive schemes but were structured to mature concurrently. Castle Minerals did not disclose reasons for non-exercise, which could relate to share price performance relative to exercise prices or strategic decisions by option holders.
Capital Structure and Outstanding Unquoted Securities
Following the expiry of CDTAO and CDTAD options, Castle Minerals’ unquoted securities portfolio now comprises four option series with varying exercise prices and expiry dates. The CDTAE series includes 12,699,985 options expiring on 22 December 2026 with a $0.15 exercise price, lower than the expired options. The largest unquoted option holding is the CDTAF series, with 97,277,257 options expiring on 31 May 2028 at an exercise price of $0.12, reflecting a staggered maturity approach.
Additional holdings include 1,299,997 options under CDTAN expiring on 31 October 2026 at $0.54 exercise price and 22,566,667 performance rights under CDTAG. The quoted ordinary shares remain at 177,145,535 fully paid shares. This layered capital structure is typical among ASX-listed exploration companies, balancing employee incentives, financing flexibility, and shareholder alignment. The staggered expiry dates through 2028 indicate a multi-year convertible securities maturity schedule.
Effect of Option Expiry on Share Register and Dilution
The expiry of 5,429,504 unquoted options reduces potential future dilution for Castle Minerals’ ordinary shareholders, as these options will no longer convert into shares. Despite this reduction, approximately 133.8 million unquoted options and performance rights remain outstanding, representing a significant potential dilution relative to the 177.1 million quoted shares.
The largest remaining option series, CDTAF with 97.3 million options at a $0.12 exercise price expiring in May 2028, poses the most substantial dilution risk if the share price exceeds this strike price. The removal of the CDTAO and CDTAD series, each at $0.225 exercise price, eliminates one dilution layer, though the overall impact is modest given the scale of outstanding convertible securities.
Role of Unquoted Options in Castle Minerals’ Capital Management
As an Australian mineral exploration company, Castle Minerals uses unquoted options as tools for capital management and employee retention, consistent with sector norms. These options enable the company to incentivize technical and management staff without immediate cash expenditure, preserving funds for exploration activities. The expired CDTAO and CDTAD options likely formed part of employee incentive plans or capital arrangements, with their non-exercise possibly reflecting share price trends or employment changes.
The exploration sector commonly employs staggered option expiry schedules to align employee interests with long-term company value while managing dilution risk. Castle Minerals’ retention of multiple option series expiring through 2028 demonstrates ongoing use of this strategy. Exercise prices ranging from $0.12 to $0.54 suggest issuance at different market conditions. The non-transferable status of CDTAO options indicates typical restrictions for employee options.
Compliance and ASX Reporting for Expired Securities
Castle Minerals filed an Appendix 3H notice with the ASX on 21 July 2026, formally documenting the expiry of these securities as required under ASX Listing Rules. This notification ensures market transparency regarding changes in issued capital and allows the ASX to maintain accurate capitalization records. The timing of the filing, one day after expiry, reflects prompt compliance.
The ASX notes that figures may vary if other capital management transactions are processed concurrently. Castle Minerals’ disclosure supports continuous market disclosure obligations, maintaining investor confidence and market integrity by providing updated share register information.
Timeline of Convertible Securities Expiry
The 20 July 2026 expiry date for CDTAO and CDTAD options was the contractual maturity point established at issuance. Options must be exercised before this date or they lapse. Remaining options expire on various dates: CDTAE on 22 December 2026, CDTAN on 31 October 2026, and CDTAF on 31 May 2028. Performance rights under CDTAG may have distinct vesting and expiry terms.
This staggered expiry schedule means Castle Minerals will encounter sequential maturity events through 2026 to 2028, each requiring ASX notification and capital register updates. Investors should monitor these dates as they may affect dilution and share capital structure depending on holder decisions at expiry.
Issued Capital and Market Capitalization Considerations
After the expiry event, Castle Minerals’ issued capital consists of 177,145,535 quoted ordinary shares and about 133.8 million unquoted options and performance rights. Full conversion of all unquoted securities would increase the ordinary share count by roughly 43%, a significant factor for investors evaluating fully diluted equity.
The company did not disclose the current share price, limiting assessment of the likelihood of option exercise relative to strike prices. The ASX uses disclosed capital figures for market capitalization and free float calculations relevant to index inclusion and market surveillance. The removal of expired options slightly lowers total securities but leaves the quoted share count unchanged. Investors should consider the large unquoted options portfolio when analyzing dilution, ownership, and voting power implications.
Sector Context: Use of Options in Australian Mineral Exploration
Unquoted options are standard capital management instruments among Australian mineral exploration companies, particularly mid-tier and junior firms. Given the long timelines from discovery to production, extended option expiry horizons align with long-term incentive plans. Castle Minerals’ multi-year option portfolio expiring through 2028 reflects this sector approach, supporting retention across exploration and development phases.
The exercise prices of remaining options, from $0.12 to $0.54, likely correspond to issuance periods with varying share price levels. Lower strike prices on recent issuances may indicate adjustments to maintain incentive value amid share price declines. The non-exercise of CDTAO and CDTAD options at $0.225 suggests the ordinary share price did not sufficiently exceed these levels or other factors led holders to forfeit options at expiry.
